Skip to main content

XBI Industry — Biotech ETF (XBI)

Industry — Biotech · Benchmark: Index Benchmark · Domiciled in US

AUM
$13.6B
Expense ratio
61.00%
Inception
2009-11-15
VMCI-Composite
57/100
5y CAGR
7.8%

VMCI-Composite holdings score

ValueMarkers builds the VMCI-Composite by taking the underlying VMCI score for each of the ETF's top-10 holdings and weighting it by the holding's share of the fund. The number summarizes the fundamentals of the largest positions on the five-pillar framework — Value, Quality, Integrity, Growth, Risk.

XBI Industry — Biotech ETF — analysis

XBI Industry — Biotech ETF runs $13.6B against Index Benchmark, with 61 bps of annual cost. The XBI ticker is the listing on the primary US exchange; the strategy has been live since 2009 in the industry — biotech category.

Composite quality on XBI's top-10 sleeve: VMCI of 57/100. The number aggregates Value, Quality, Integrity, Growth, and Risk pillars across the funds' largest positions. The cohort comparison reads mid-table composite quality.

XBI performance ledger: 5y CAGR 7.8% (benchmark: 6.0%), 3y 8.1%, 1y 13.6%, YTD -4.2%. The 5y delta to index is 1.8 pp annualized.

Distribution metrics on XBI: 1.30% TTM yield, 5.8% 5y dividend CAGR. The two numbers together set the carry-and-growth math that income allocators run on this kind of fund.

On portfolio structure, XBI carries a 30% top-10 weight and a Technology-led sector mix (28%). The fund's largest single position is AAPL at 3.45%.

Funds that sit closest to XBI on the industry — biotech shelf: SPY, VOO, VTI. Allocators usually choose between them on cost (61 bps on this fund), distribution profile, and underlying methodology rather than headline category.

Top 25 holdings

#TickerWeightVMCI
1AAPL3.45%53
2MSFT3.32%81
3NVDA3.32%50
4AMZN3.28%57
5GOOGL3.19%43
6META2.93%44
7BRK-B2.89%65
8TSLA2.80%73
9V2.67%45
10JPM2.41%64
11UNH2.20%70
12XOM2.03%57
13JNJ1.90%49
14PG1.77%68
15MA1.77%41
16HD1.72%49
17MRK1.64%83
18AVGO1.38%56
19PEP1.16%42
20COST0.99%84
21KO0.99%83
22WMT0.78%71
23BAC0.60%51
24CVX0.47%44
25ADBE0.34%63

Performance & income

YTD
-4.2%
1y total return
13.6%
3y CAGR
8.1%
5y CAGR vs benchmark
7.8% / 6.0%
Dividend yield
1.30%
5y distribution CAGR
5.8%

Comparable ETFs

Browse more

Data refreshed at request time and cached for 6 hours. As of 2026-05-14.

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.